SEC 13F Intelligence

Trv GP IV, LLC / MAZE

Trv GP IV, LLC’s Maze Therapeutics Inc Position

Does Trv GP IV, LLC own Maze Therapeutics Inc (MAZE)? Yes — 4.47M shares worth $134M (+50.04% of its 13F portfolio) as of Q1 2026.

Position Value
$134M
Q1 2026
Shares
4.47M
% of Portfolio
+50.04%
Quarters Held
5
currently held

Position History MAZE

Reported value by quarter
Q1 ’25: $67MQ1 ’25Q2 ’25: $75MQ2 ’25Q3 ’25: $157MQ3 ’25Q4 ’25: $185MQ4 ’25Q1 ’26: $134MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.47M$134M+50.04%
Q4 20254.47M$185M+72.65%
Q3 20256.07M$157M+57.49%
Q2 20256.07M$75M+45.63%
Q1 20256.07M$67M+72.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP IV, LLC’s full portfolio or all institutional holders of MAZE.